Clinical trials
Phase 1 Scleroderma, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 12 |
| 2025 | 29 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 33 |
| Not yet recruiting | 18 |
| Completed | 15 |
| Terminated | 7 |
| Active, not recruiting | 5 |
| Unknown status | 4 |
| Withdrawn | 4 |
| Suspended | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanjing Bioheng Biotech Co., Ltd. | 4 |
| The Children's Hospital of Zhejiang University School of Medicine | 4 |
| Beijing GoBroad Hospital | 3 |
| China Immunotech (Beijing) Biotechnology Co., Ltd. | 3 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 3 |
| RenJi Hospital | 3 |
| Chongqing Precision Biotech Co., Ltd | 2 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2 |
| Medical University of South Carolina | 2 |
| Ruijin Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 91 |
| Lupus Erythematosus, Systemic | 47 |
| Myositis | 35 |
| Autoimmune Diseases | 26 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 22 |
| Sjogren's Syndrome | 18 |
| Arthritis, Rheumatoid | 15 |
| Scleroderma, Diffuse | 15 |
| Lupus Nephritis | 13 |
| Dermatomyositis | 10 |
Trials
Showing 76 to 91 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.